Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LINCOLN.NS ROE (Return on Equity)

The ROE (Return on Equity) of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 12.26%.

ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.

LINCOLN.NS ROE (Return on Equity) - Historical Value
Date Value
2025-03-31 12.26%
2024-03-31 15.74%
2023-03-31 14.51%
2022-03-31 16.02%
2021-03-31 16.58%
2020-03-31 16.43%
2019-03-31 18.08%
2018-03-31 15.44%
2017-03-31 14.62%
2016-03-31 16.49%
LINCOLN.NS ROE (Return on Equity) - Peers Comparison